Arkolith/Insider Trading/MLTX/Form 4

Santos da Silva Jorge

Chief Executive Officer, DirectorMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Feb 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.6M
Net Open-Market Flow
-$3.6M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2024Sell(S)20K$57.44$1.1M3.1M
Feb 16, 2024Sell(S)20K$60.15$1.2M3.1M
Feb 15, 2024Sell(S)20K$60.18$1.2M3.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-015446) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML